MicroRNA-34a regulates cardiac ageing and function.
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Ageing is the predominant risk factor for cardiovascular diseases and contributes to a significantly worse outcome in patients with acute myocardial infarction. MicroRNAs (miRNAs) have emerged as crucial regulators of cardiovascular function and some miRNAs have key roles in ageing. We propose that altered expression of miRNAs in the heart during ageing contributes to the age-dependent decline in cardiac function. Here we show that miR-34a is induced in the ageing heart and that in vivo silencing or genetic deletion of miR-34a reduces age-associated cardiomyocyte cell death. Moreover, miR-34a inhibition reduces cell death and fibrosis following acute myocardial infarction and improves recovery of myocardial function. Mechanistically, we identified PNUTS (also known as PPP1R10) as a novel direct miR-34a target, which reduces telomere shortening, DNA damage responses and cardiomyocyte apoptosis, and improves functional recovery after acute myocardial infarction. Together, these results identify age-induced expression of miR-34a and inhibition of its target PNUTS as a key mechanism that regulates cardiac contractile function during ageing and after acute myocardial infarction, by inducing DNA damage responses and telomere attrition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“miR 124, miR-34a/b/c, and miR-29a/b/c are upregulated in response to p53 activation and facilitate cellular senescence by downregulating survival and cell proliferation factors (Hermeking, 2010; Boon et al., 2013; Hu et al., 2014; Xu S. et al., 2019).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Boon et al., 2013
Citations
Cites
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Telomere measurement by quantitative PCR
Cawthon, R. M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.10.e47 · Cited by 3,487
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805038105 · Cited by 1,844
Identifying differentially expressed genes using false discovery rate controlling procedures
Reiner, A., Yekutieli, D., & Benjamini, Y. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btf877 · Cited by 1,765
miR-34a repression of SIRT1 regulates apoptosis
Yamakuchi, M., Ferlito, M., & Lowenstein, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801613105 · Cited by 1,342
Telomere dysfunction induces metabolic and mitochondrial compromise
Sahin, E., Colla, S., Liesa, M., Moslehi, J., Müller, F. L., Guo, M., Cooper, M., Kotton, D., Fabian, A. J., Walkey, C., et al. (2011) · Nature · doi:10.1038/nature09787 · Cited by 1,319
MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
Bonauer, A., Carmona, G., Iwasaki, M., Mione, M., Koyanagi, M., Fischer, A., Burchfield, J., Fox, H., Doebele, C., Ohtani, K., et al. (2009) · Science · doi:10.1126/science.1174381 · Cited by 1,215
Self-citationPervasive roles of microRNAs in cardiovascular biology
Small, E. M., & Olson, E. N. (2011) · Nature · doi:10.1038/nature09783 · Cited by 1,180
Cited by
Items 101–200 of 828
Deriving a cardiac ageing signature to reveal MMP-9-dependent inflammatory signalling in senescence
Ma, Y., Chiao, Y. A., Clark, R., Flynn, E. R., Yabluchanskiy, A., Ghasemi, O., Zouein, F., Lindsey, M. L., & Jin, Y.-F. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv128 · Cited by 114
Xiong, H., Chen, S., Lai, L., Yang, H., Xu, Y., Pang, J., Su, Z., Lin, H., & Zheng, Y. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.03.013 · Cited by 124
MicroRNA-34a: the bad guy in age-related vascular diseases
Raucci, A., Macrì, F., Castiglione, S., Badi, I., Vinci, M. C., & Zuccolo, E. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03979-4 · Cited by 123
Lv, P., Zhou, M., He, J., Meng, W., Ma, X., Dong, S., Meng, X., Zhao, X. Y., Wang, X., & He, F. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15045774 · Cited by 123
“MiR-34a was demonstrated as a pro-apoptotic factor in cardiac contractile function during ageing and after AMI [24,25].”
BackgroundDevelopment of Long Noncoding RNA-Based Strategies to Modulate Tissue Vascularization
Fiedler, J., Breckwoldt, K., Remmele, C. W., Hartmann, D., Dittrich, M., Pfanne, A., Just, A., Xiao, K., Kunz, M., Müller, T., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.081 · Cited by 113
“Numerous reports have proved that single miRs have a master role in the regulation of cardiovascular pathophysiology and serve as interesting treatment targets (1,2).”
BackgroundLuong, D., Kesharwani, P., Alsaab, H. O., Sau, S., Padhye, S., Sarkar, F. H., & Iyer, A. K. (2017) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2017.06.025 · Cited by 110
microRNA Therapeutics in Cardiovascular Disease Models
Dangwal, S., & Thum, T. (2013) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135957 · Cited by 117
Genome-wide profiling of the microRNA-mRNA regulatory network in skeletal muscle with aging
Kim, J. Y., Park, Y.-K., Lee, K.-P., Lee, S.-M., Kang, T.-W., Kim, H.-J., Dho, S. H., Kim, S.-Y., & Kwon, K.-S. (2014) · Aging · doi:10.18632/aging.100677 · Cited by 113
Oxidative Stress in Mesenchymal Stem Cell Senescence: Regulation by Coding and Noncoding RNAs
Vono, R., Jover, E., Spinetti, G., & Madeddu, P. R. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7294 · Cited by 120
“MiR-34a has been largely associated with aging and cardiovascular diseases in particularly affecting the function of cardiovascular cells (7).”
Kiss, T., Giles, C. B., Tarantini, S., Yabluchanskiy, A., Balasubramanian, P., Gautam, T., Csípő, T., Nyúl‐Tóth, Á., Lipécz, Á., Szabó, C., et al. (2019) · GeroScience · doi:10.1007/s11357-019-00095-x · Cited by 121
Cardiac cell senescence: molecular mechanisms, key proteins and therapeutic targets
Luan, Y., Zhu, X., Jiao, Y., Liu, H., Huang, Z., Pei, J., Xu, Y., Yang, Y., & Ren, K. (2024) · Cell Death Discovery · doi:10.1038/s41420-023-01792-5 · Cited by 122
“Aging hearts also show elevated miR-34 levels, reducing cell contractility [34].”
BackgroundInfluence of the Confounding Factors Age and Sex on MicroRNA Profiles from Peripheral Blood
Meder, B., Backes, C., Haas, J., Leidinger, P., Stähler, C., Großmann, T., Vogel, B., Frese, K., Giannitsis, E., Katus, H. A., et al. (2014) · Clinical Chemistry · doi:10.1373/clinchem.2014.224238 · Cited by 112
Self-citationRipa, R., Dolfi, L., Terrigno, M., Pandolfini, L., Savino, A., Arcucci, V., Groth, M., Terzibasi Tozzini, E., Baumgart, M., & Cellerino, A. (2017) · BMC Biology · doi:10.1186/s12915-017-0354-x · Cited by 101
Small RNA Detection by in Situ Hybridization Methods
Urbanek-Trzeciak, M. O., Nawrocka, A., & Krzyżosiak, W. J. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160613259 · Cited by 117
Vogel, P., Schneider, M. F., Wettengel, J., & Stafforst, T. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201402634 · Cited by 107
Ruggeri, C., Gioffré, S., Achilli, F., Colombo, G. I., & D’Alessandra, Y. (2018) · Heart Failure Reviews · doi:10.1007/s10741-017-9653-0 · Cited by 104
“Previous works had shown that miR-34a can trigger apoptosis in tumor cells [67] and cardiomyocytes [68].”
BackgroundmicroRNA in Cardiovascular Aging and Age-Related Cardiovascular Diseases
de Lucia, C., Komici, K., Borghetti, G., Femminella, G. D., Bencivenga, L., Cannavò, A., Corbi, G., Ferrara, N., Houser, S. R., Koch, W. J., et al. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00074 · Cited by 114
“Remarkably, miR-34a expression was significantly augmented in aged human hearts, in a mouse model of accelerated aging or post-MI (62).”
BackgroundInfluentialFibromiRs: translating molecular discoveries into new anti-fibrotic drugs
Pottier, N., Cauffiez, C., Perrais, M., Barbry, P., & Mari, B. P. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.01.003 · Cited by 106
Zheng, K., Hu, F., Zhou, Y., Zhang, J., Zheng, J., Lai, C., Xiong, W., Cui, K., Hu, Y., Han, Z., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22196-y · Cited by 110
Awada, H. K., Hwang, M. P., & Wang, Y. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.12.025 · Cited by 108
“investigated to prevent cardiomyocyte death [98, 99].”
Dicer and microRNAs protect adult dopamine neurons
Chmielarz, P., Konovalova, J., Najam, S. S., Alter, H., Piepponen, T. P., Erfle, H., Sonntag, K. C., Schütz, G., Vinnikov, I. A., & Domanskyi, A. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.214 · Cited by 99
Meijles, D. N., Sahoo, S., Al Ghouleh, I., Amaral, J. H., Bienes-Martinez, R., Knupp, H. E., Attaran, S., Sembrat, J. C., Nouraie, S. M., Rojas, M. M., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aaj1784 · Cited by 96
Wu, X., Wang, L., Wang, K., Li, J., Chen, R., Wu, X., Ni, G., Liu, C., Das, S., Sluijter, J. P. G., et al. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.07.004 · Cited by 101
Roles of microRNA-34a targeting SIRT1 in mesenchymal stem cells
Zhang, F., Cui, J., Liu, X., Lv, B., Liu, X., Xie, Z., & Yu, B. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0187-x · Cited by 103
Trembinski, D. J., Bink, D. I., Theodorou, K., Sommer, J., Fischer, A., van Bergen, A. S., Kuo, C., Costa, I. G., Schürmann, C., Leisegang, M. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15995-2 · Cited by 103
Self-citationCardiac fibrosis in the ageing heart: Contributors and mechanisms
Lu, L., Guo, J., Hua, Y., Huang, K. W., Magaye, R., Cornell, J., Kelly, D. J., Reid, C. M., Liew, D., Zhou, Y., et al. (2017) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12753 · Cited by 104
Martino, M. T. D., Gullà, A., Cantafio, M. E. G., Altomare, E., Amodio, N., Leone, E., Morelli, E., Lio, S. G., Caracciolo, D., Rossi, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089659 · Cited by 103
The role of microRNAs in heart failure
Wang, H., & Cai, J. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.034 · Cited by 106
Small non-coding RNA therapeutics for cardiovascular disease
Shah, A. M., & Giacca, M. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac463 · Cited by 100
Early biomarkers of doxorubicin-induced heart injury in a mouse model
Desai, V. G., Kwekel, J. C., Vijay, V., Moland, C. L., Herman, E. H., Lee, T., Han, T., Lewis, S. M., Davis, K. J., Muskhelishvili, L., et al. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.10.006 · Cited by 100
Aging and Regeneration in Vertebrates
Sousounis, K., Baddour, J., & Tsonis, P. A. (2014) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/b978-0-12-391498-9.00008-5 · Cited by 107
Kirchhof, P., Medicine, E. C. R. A. E. A. W. S. O. P., Sipido, K. R., Medicine, E. C. R. A. E. A. W. S. O. P., Cowie, M. R., Medicine, E. C. R. A. E. A. W. S. O. P., Eschenhagen, T., Medicine, E. C. R. A. E. A. W. S. O. P., Fox, K. A. A., Medicine, E. C. R. A. E. A. W. S. O. P., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu312 · Cited by 90
Self-citationArunachalam, G., Lakshmanan, A. P., Samuel, S. M., Triggle, C. R., & Ding, H. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.226894 · Cited by 95
Cell cycle-targeting microRNAs promote differentiation by enforcing cell-cycle exit
Otto, T., Candido, S. V., Pilarz, M. S., Sicińska, E., Bronson, R. T., Bowden, M., Stukan, I., Mulry, K. A., Fassl, A., Han, R. C., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702914114 · Cited by 97
“In contrast, ablation of individual members of the miR-34/449 family in mice did not uncover any essential functions in vivo (15–17), apart from minor defects in bone development (18) and improved heart function during aging (19).”
The emerging role of micro RNA s in cardiovascular disease
Mäegdefessel, L. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12298 · Cited by 103
Tocchetti, C. G., Ameri, P., de Boer, R. A., D’Alessandra, Y., Russo, M., Sorriento, D., Ciccarelli, M., Kiss, B., Bertrand, L., Dawson, D. K., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa222 · Cited by 100
Wu, T., Chen, Y., Du, Y., Jin, T., Zhou, Z., & Yang, Z. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000489383 · Cited by 97
Over-expression of miR-34a induces rapid cognitive impairment and Alzheimer’s disease-like pathology
Sarkar, S., Engler-Chiurazzi, E. B., Cavendish, J. Z., Povroznik, J. M., Russell, A. E., Quintana, D. D., Mathers, P. H., & Simpkins, J. W. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146327 · Cited by 91
Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases
Hua, C., Liu, X., Liang, L., Wang, L., & Zhong, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.784044 · Cited by 96
“More importantly, inhibition of miR-34a improves cardiac function during aging and post MI by reducing cell death and fibrosis by targeting PNUTS, which is an essential regulator of endogenous cardiac regeneration (Table 1; Figure 1) (20, 29).”
BackgroundMicroRNA as a Therapeutic Target in Cardiac Remodeling
Chen, C., Ponnusamy, M., Liu, C., Gao, J., Wang, K., & Li, P. (2017) · BioMed Research International · doi:10.1155/2017/1278436 · Cited by 93
“This leads to functional decline of the heart [107].”
BackgroundChen, J., Wu, Y. J., Fu, C., Cao, H., Tan, X., Shi, W., & Wu, Z. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111619 · Cited by 91
Hsu, A., Chen, S., Chang, Y., Chen, H., & Chu, P. (2014) · BioMed Research International · doi:10.1155/2014/418628 · Cited by 90
Chaudhari, U., Nemade, H., Gaspar, J. A., Hescheler, J., Hengstler, J. G., & Sachinidis, A. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1668-0 · Cited by 90
“…miR-34b and miR-34c (miR-34 family members) are up-regulated during rat cardiac hypertrophy (Feng et al. 2014), in the aged hearts of mice (Boon et al. 2013), in mouse hearts with myocardial infarction (Bernardo et al. 2012) and in diabetic ischaemic heart failure patients (Greco et al.…”
BackgroundInfluentialLi, X., Cheng, W., Li, D., Wu, J., Ding, X., Cheng, Q. J., & Ding, S. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.01.048 · Cited by 88
Kim, J.-H., Lee, K.-S., Lee, D.-K., Kim, J., Kwak, S.-N., Ha, K., Choe, J., Won, M., Cho, B. R., Jeoung, D., et al. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.5856 · Cited by 92
“For example, miR-34a is known to regulate cardiac aging and function via inhibition of senescence-associated PNUTS expression (6). miRs-199a/590 is also suggested to stimulate cardiac regeneration via proliferation of adult cardiomyocytes (22).”
Regulation of SIRT1 by MicroRNAs
Choi, S., & Kemper, J. K. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0297-1 · Cited by 92
“…in rat liver (Li et al., 2011), miR-34 levels are increased with aging in drosophila and increased neurodegenerative disorders (Liu et al., 2012), and that miR-34a levels are also elavated in aged heart and downregulation of miR-34a reduced age-related cardiomyocyte cell death (Boon et al., 2013).”
BackgroundInfluentialNakou, E. S., Parthenakis, F. I., Kallergis, E. M., Marketou, M. E., Nakos, K. S., & Vardas, P. E. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.02.039 · Cited by 88
Vascular aging: implications for cardiovascular disease and therapy
Ghebre, Y. T., Yakubov, E., Wong, W. T., & Krishnamurthy, P. (2016) · Translational Medicine · doi:10.4172/2161-1025.1000183 · Cited by 87
Molecular biomarkers in cardiac hypertrophy
Liu, Z., Li, C., Liu, Q., Xu, W., & Zhou, X. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14129 · Cited by 89
Postnatal telomere dysfunction induces cardiomyocyte cell-cycle arrest through p21 activation
Aix, E., Gutiérrez-Gutiérrez, Ó., Sánchez-Ferrer, C., Aguado, T., & Flores, I. (2016) · Journal of Cell Biology · doi:10.1083/jcb.201510091 · Cited by 84
“Previous work indicates that telomerase and telomeres influence the proliferation and apoptosis rate in mature CMs (Leri et al., 2001, 2003; Oh et al., 2001; Boon et al., 2013; Bär et al., 2014), but their role in CMs during postnatal maturation and cardiac regeneration remains unknown.”
Chen, Q., Yang, F., Guo, M., Wen, G., Zhang, C., Luong, L. A., Zhu, J., Xiao, Q., & Zhang, L. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.10.017 · Cited by 86
Xiao, Z., Li, C. H., Chan, S. L., Xu, F., Lu, F., Wang, Y., Jiang, J.-D., Sung, J. J. �., Cheng, C. H. K., & Chen, Y. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0855 · Cited by 91
A transgenic resource for conditional competitive inhibition of conserved Drosophila microRNAs
Fulga, T. A., McNeill, E. M., Binari, R. C., Yelick, J., Blanche, A., Booker, M., Steinkraus, B. R., Schnall-Levin, M., Zhao, Y. B., DeLuca, T. F., et al. (2015) · Nature Communications · doi:10.1038/ncomms8279 · Cited by 95
“However, to our knowledge, only miR-1 and miR-34 have been implicated by LOF in vertebrate cardiac and/or skeletal muscle function 43, 50 .”
Cardiac Aging: From Basic Research to Therapeutics
Yan, M., Sun, S., Xu, K., Huang, X., Dou, L., Pang, J., Tang, W., Shen, T., & Li, J. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9570325 · Cited by 91
“The overexpression of phosphatase 1 nuclear targeting subunit (PNUTS, also known as PPP1R10), a target gene of miR-34a, reduces DNA damage and cardiomyocyte apoptosis and improves cardiac function [75].”
BackgroundHardeland, R. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms151018221 · Cited by 83
“The latter was shown to target the 3'-UTR of Pnuts mRNA and, thereby, to age-dependently reduce the level of PNUTS protein [134], i.”
BackgroundAge-associated pro-inflammatory remodeling and functional phenotype in the heart and large arteries
Wang, M., & Shah, A. M. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.02.004 · Cited by 82
“Moreover, miR-34a inhibition reduces cell death and fibrosis following acute myocardial infarction, reduces telomere shortening, DNA damage responses and cardiomyocyte apoptosis, and improves functional recovery after acute myocardial infarction [118].”
BackgroundEmerging Roles for MicroRNAs in Perioperative Medicine
Neudecker, V., Brodsky, K. S., Kreth, S., Ginde, A. A., & Eltzschig, H. K. (2015) · Anesthesiology · doi:10.1097/aln.0000000000000969 · Cited by 93
Frères, P., Bouznad, N., Servais, L., Josse, C., Wenric, S., Poncin, A., Thiry, J., Moonen, M. L., Oury, C., Lancellotti, P., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4015-4 · Cited by 84
“demonstrated that miR-34a was involved in the alteration of cardiac contractile function after AMI, by inducing telomere attrition [29].”
Senescent endothelial cells: Potential modulators of immunosenescence and ageing
Pantsulaia, I., Ciszewski, W. M., & Niewiarowska, J. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.05.011 · Cited by 84
Telomere shortening and metabolic compromise underlie dystrophic cardiomyopathy
Chang, A. C. Y., Ong, S.-G., LaGory, E. L., Kraft, P. E., Giaccia, A. J., Wu, J. C., & Blau, H. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615340113 · Cited by 81
“Others have shown that, loss of telomere protection due either to reduced levels of a shelterin or of the miR-34 target, PNUTS, is associated with heart disease (26, 27).”
BackgroundMicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat
Piegari, E., Russo, R., Cappetta, D., Esposito, G., Urbanek, K., Dell’Aversana, C., Altucci, L., Berrino, L., Rossi, F., & Angelis, A. D. (2016) · Oncotarget · doi:10.18632/oncotarget.11468 · Cited by 83
“In this paper, we have focused our attention on miR-34a, a miRNA involved in several cellular processes implicated in DOXO cardiotoxicity, such as apoptosis and senescence [11] and recently recognized as a key regulator in cardiac dysfunction and ageing [9, 10, 12, 17].”
BackgroundInfluentialThe mitochondrial genome in aging and senescence
Lauri, A., Pompilio, G., & Capogrossi, M. C. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.07.001 · Cited by 80
“Mice lacking miR-34a show an improved recovery fter myocardial infarction (Boon et al., 2013).”
BackgroundSIRT2 counteracts primate cardiac aging via deacetylation of STAT3 that silences CDKN2B
Ye, Y., Yang, K., Liu, H., Yu, Y., Song, M., Huang, D., Lei, J., Zhang, Y., Liu, Z., Chu, Q., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00486-y · Cited by 87
Huang, J., Sun, W., Huang, H., Ye, J., Pan, W., Zhong, Y., Cheng, C., You, X., Liu, B., Xiong, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094382 · Cited by 80
“Indeed, level of miR-34a expression is various in different pathological conditions; for example, in the ageing heart [25] or myocardial infarction [26], miR-34a was up-regulated, whereas in a number of cancers, such as lung cancer and bladder cancer [27,28], miR-34a expression was markedly down-regulated.”
BackgroundRetractedFomison-Nurse, I., Saw, E. E. L., Gandhi, S., Munasinghe, P. E., Van Hout, I., Williams, M. J. A., Galvin, I., Bunton, R., Davis, P., Cameron, V., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0047-6 · Cited by 77
“MiR-34a has been linked to the regulation of several proteins including Akt [16], PNUTS (also known as Ppp1r10) [14], and sirtuin 1 (SIRT1) [17], all of which have actions relevant to the diabetic heart.”
InfluentialXu, S., Wu, W., Huang, H., Huang, R., Xie, L., Su, A., Liu, S., Zheng, R., Yuan, Y., Zheng, H., et al. (2019) · Aging Cell · doi:10.1111/acel.12918 · Cited by 79
“Among these miRNAs, miR‐ 34a and miR‐29 have been demonstrated to be typical Aging‐related miRNAs (Boon et al., 2013; Hu et al., 2014); in addition, miR‐194 was closely associated with cellular senescence as well (Xu et al.”
BackgroundMicroRNAs in cardiovascular disease
Gurha, P. (2016) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000280 · Cited by 78
DICER: structure, function, and regulation
Vergani-Junior, C. A., Tonon-da-Silva, G., Inan, M. D., & Mori, M. A. (2021) · Biophysical Reviews · doi:10.1007/s12551-021-00902-w · Cited by 85
“ciation between DICER and disease pathogenesis (Mori et al. 2012; Boon et al. 2013; Theotoki et al. 2020).”
Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury
Lee, T. J., Yuan, X., Kerr, K. M., Yoo, J. Y., Kim, D., Kaur, B., & Eltzschig, H. K. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.019026 · Cited by 80
“The level of miR-34a increases as the heart ages, and its inhibition prevents age-associated cardiomyocyte death while facilitating the recovery of AMI.”
BackgroundInfluentialCirculating small noncoding RNAs as biomarkers of aging
Dhahbi, J. M. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.02.005 · Cited by 82
Cellular cross-talks in the diseased and aging heart
Wagner, J. U. G., & Dimmeler, S. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.11.152 · Cited by 84
Self-citationXia, W., Chen, H., Chen, D., Ye, Y., Xie, C., & Hou, M. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001293 · Cited by 86
HypoxamiRs: regulators of cardiac hypoxia and energy metabolism
el Azzouzi, H., Leptidis, S., Doevendans, P. A., & Windt, L. J. D. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.06.008 · Cited by 81
“…(LNA)-modified ‘anti-mirs’ (Box 1) were employed to therapeutically silence miR-34a in the mouse, and in both cases this new therapeutic approach improved systolic function and attenuated pathological cardiac remodeling following sustained pressure overload or acute myocardial infarction [37,40].”
Bernardo, B. C., Gao, X., Tham, Y. K., Kiriazis, H., Winbanks, C. E., Ooi, J. Y. Y., Boey, E. J. H., Obad, S., Kauppinen, S., Gregorevic, P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090337 · Cited by 83
In Vivo Therapeutic Success of MicroRNA‐155 Antagomir in a Mouse Model of Lupus Alveolar Hemorrhage
Zhou, S., Wang, Y., Meng, Y., Xiao, C., Liu, Z., Brohawn, P. Z., Higgs, B. W., Jallal, B., Jia, Q., Qu, B., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39485 · Cited by 79
Novel therapeutic strategies for cardioprotection
Sluijter, J. P. G., Condorelli, G., Davidson, S. M., Engel, F. B., Ferdinandy, P., Hausenloy, D. J., Lecour, S., Madonna, R., Ovize, M., Ruiz‐Meana, M., et al. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.05.005 · Cited by 80
Regulation of cardiomyocyte fate plasticity: a key strategy for cardiac regeneration
Gong, R., Jiang, Z., Zagidullin, N. S., Liu, T., & Cai, B. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00413-2 · Cited by 77
“The inhibited expression of miR-34 family members or by increasing the expression of target genes (such as Vinculin, Pofut1and PNUTS) can effectively improve the impaired cardiac functions.(165,166) It has been found that miRNAs can regulate a variety of signaling pathways involved in cardiac regeneration,(167,168) in…”
BackgroundTargeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges
Kwekkeboom, R. F. J., Lei, Z., Doevendans, P. A., Musters, R. J. P., & Sluijter, J. P. G. (2014) · Clinical Science · doi:10.1042/cs20140005 · Cited by 81
Luo, X.-Y., Qu, S.-L., Tang, Z., Zhang, Y. E., Liu, M., Peng, J., Tang, H. R., Yu, K., Zhang, C., Ren, Z., et al. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.07.019 · Cited by 79
Blasco‐Baqué, V., Coupé, B., Fabre, A., Handgraaf, S., Gourdy, P., Arnal, J., Courtney, M., Schuster, C., Guardiola, B., Tercé, F., et al. (2017) · Diabetologia · doi:10.1007/s00125-017-4209-3 · Cited by 77
“The expression of each miRNA was normalised to U6 small nuclear RNA (snRNA) expression [23].”
BackgroundMethodCirculating exosomal miRNAs in cardiovascular disease pathogenesis: New emerging hopes
Aghabozorgi, A. S., Ahangari, N., Eftekhaari, T. E., Torbati, P. N., Bahiraee, A., Ebrahimi, R., & Pasdar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28942 · Cited by 75
Concise Review: MicroRNAs as Modulators of Stem Cells and Angiogenesis
Kane, N. M., Thrasher, A. J., Angelini, G. D., & Emanueli, C. (2014) · Stem Cells · doi:10.1002/stem.1629 · Cited by 74
Functional Role of Calstabin2 in Age-related Cardiac Alterations
Yuan, Q., Chen, Z., Santulli, G., Gu, L., Yang, Z.-G., Yuan, Z.-Q., Zhao, Y.-T., Xin, H., Deng, K.-Y., Wang, S., et al. (2014) · Scientific Reports · doi:10.1038/srep07425 · Cited by 76
MicroRNA Profiling of Pericardial Fluid Samples from Patients with Heart Failure
Linna-Kuosmanen, S., Hartikainen, J. E. K., Hippeläinen, M., Kokki, H. J., Levonen, A., & Tavi, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119646 · Cited by 78
“In addition, miR34a-5p, which was detected in high amounts in all pericardial fluid samples, has been identified as a factor contributing to the aging-related decline in cardiac function [73,74].”
BackgroundAge-dependent increase of oxidative stress regulates microRNA-29 family preserving cardiac health
Heid, J., Cencioni, C., Ripa, R., Baumgart, M., Atlante, S., Milano, G., Scopece, A., Kuenne, C., Guenther, S., Azzimato, V., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16829-w · Cited by 70
Self-citationGhosh, N., & Katare, R. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0684-1 · Cited by 76
“Among the three isoforms, miR-34a is abundantly expressed in cardiomyocytes [106, 107].”
BackgroundChen, G., Li, H., Li, X., Li, B., Zhong, L., Huang, S., Zheng, H., Li, M., Jin, G., Liao, W., et al. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.08.013 · Cited by 72
Noncoding RNAs in age-related cardiovascular diseases
Jusic, A., Thomas, P. B., Wettinger, S. B., Dogan, S., Farrugia, R., Gaetano, C., Tuna, B. G., Pinet, F., Robinson, E. L., Tual-Chalot, S., et al. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101610 · Cited by 70
Foryst‐Ludwig, A., Kreissl, M. C., Benz, V., Brix, S., Smeir, E., Bán, Z., Januszewicz, E., Salatzki, J., Grune, J., Schwanstecher, A., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.645341 · Cited by 70
“Human (GATA-4 / -sarcomeric actin ) primary cardiomyocytes (primary human cardiomyocytes) were purchased from Promocell and cultivated accordingly to the manufacturer’s instructions, as described previously (16).”
MethodFerreira, D. M. S., Afonso, M. B., Rodrigues, P. M., Simão, A. L., Pereira, D. M., Borralho, P. M., Rodrigues, C. M. P., & Castro, R. E. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00420-13 · Cited by 70
HIV-1 Tat-mediated microglial inflammation involves a novel miRNA-34a-NLRC5-NFκB signaling axis
Periyasamy, P., Thangaraj, A., Bendi, V. S., & Buch, S. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.03.011 · Cited by 70
“Several studies have demonstrated that increased expression of miRNA-34a-signalling is associated with various neurological, neuroimmune, neuroinflammatory or neurodegenerative pathologies (Agostini et al., 2011b; Bhattacharjee et al., 2016; Boon et al., 2013; Gao et al., 2013; Junker et al., 2009; Kofman et al., 2013…”
BackgroundZhu, Y., Qian, X., Li, J., Lin, X., Luo, J.-W., Huang, J., & Zhao, J. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1687492 · Cited by 71
“[24] reported that changes in heart miRNAs expression during aging resulted in a decrease in cardiac function, and miR-34a family was significantly upregulated in the heart of aging mice.”
BackgroundMonogenic Diseases of DNA Repair
Keijzers, G., Bakula, D., & Scheibye‐Knudsen, M. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1703366 · Cited by 73
Kong, L., Li, H., Zhang, X., Zhuo, Y., Chai, Y., & Yuan, R. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c00190 · Cited by 69
The role of microRNAs in cardiac development and regenerative capacity
Katz, M. G., Fargnoli, A. S., Kendle, A. P., Hajjar, R. J., & Bridges, C. R. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00181.2015 · Cited by 73
Heart Failure with Preserved Ejection Fraction in Older Adults
Upadhya, B., & Kitzman, D. W. (2017) · Heart Failure Clinics · doi:10.1016/j.hfc.2017.02.005 · Cited by 81
Ruiz-Meana, M., Bou-Teen, D., Ferdinandy, P., Gyongyosi, M., Pesce, M., Perrino, C., Schulz, R., Sluijter, J. P. G., Tocchetti, C. G., Thum, T., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa132 · Cited by 67
Reprogramming macrophage orientation by microRNA 146b targeting transcription factor IRF5
Peng, L., Zhang, H., Hao, Y., Xu, F., Yang, J., Zhang, R., Lu, G., Zheng, Z., Cui, M., Qi, C.-F., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.10.041 · Cited by 67
“Therefore, the development of miR-based therapeutics is of great interest in various diseases (Banno et al., 2014; Boon et al., 2013; Ge et al., 2014; Kornfeld et al., 2013; Sun et al., 2012).”
BackgroundThe Therapeutic Potential of Mirnas Regulated in Settings of Physiological Cardiac Hypertrophy
Ooi, J. Y., Bernardo, B. C., & McMullen, J. R. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.13.196 · Cited by 66
Jin, K., Xiang, Y., Tang, J., Wu, G., Li, J., Xiao, H., Li, C., Chen, Y., & Zhao, J. (2013) · Tumor Biology · doi:10.1007/s13277-013-1207-z · Cited by 67
“Recent studies demonstrated that miR-34a regulates telomere length [16].”
BackgroundInfluential
Metadata
- Authors
- Boon, R. A., Iekushi, K., Lechner, S., Seeger, T., Fischer, A., Heydt, S., Kaluza, D., Tréguer, K., Carmona, G., Bonauer, A., Horrevoets, A. J. G., Didier, N., Girmatsion, Z., Biliczki, P., Ehrlich, J. R., Katus, H. A., Müller, O. J., Potente, M., Zeiher, A. M., Hermeking, H., & Dimmeler, S.
- Affiliations
- Goethe University Frankfurt (DE)
- Pathologisches Institut (DE)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Inserm (FR)
- Heidelberg University (DE)
- Corresponding author
- Dimmeler, Stefanie
- ORCID
- Venue
- Nature
- Published
- 2013-02-20
- Volume
- 495
- Issue
- 7439
- Pages
- 107-110
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2090374150
- Cited by
- 821
- References
- 36
- Citations by year
- 2026: 29 · 2025: 37 · 2024: 41 · 2023: 42 · 2022: 64 · 2021: 45 · 2020: 61 · 2019: 59 · 2018: 72 · 2017: 84 · 2016: 75 · 2015: 85 · 2014: 90 · 2013: 34
- FWCI
- 33.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- miR-34a, cardiac aging, PNUTS, microRNA regulation, cardiomyocyte apoptosis, telomere shortening, DNA damage response, myocardial fibrosis, acute myocardial infarction, cardiac contractile function, therapeutic target
- MeSH terms
- Aging, Animals, DNA Damage, Fibrosis, Gene Expression Regulation, Heart, Mice, Inbred C57BL, Myocardial Infarction, Myocardium, Substrate Specificity, Genetic Therapy, Telomere, Apoptosis, Gene Deletion, Myocytes, Cardiac, MicroRNAs, Mice, Gene Knockout Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.